📰 Randomized Evaluation News
Page 4 - Randomized Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Randomized Evaluation. Real-time updates on events, politics, business and more.
March 25, 2022
Item 8.01 Other Events. On March 25, 2022, Vir Biotechnology, Inc. issued a press release announcing that the U.S. Food and Drug Administration has amended the Emergency Use Authorization Fact... | March 25, 2022
March 1, 2022
Children who survive an episode of acute respiratory failure that requires invasive mechanical ventilation may be at risk for lower long-term neurocognitive function.
February 2, 2022
02.02.2022 - NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, is pleased to announce the appointment of Dr. Eric Rose as the Company’s Chief Medical ... Seite 1
February 1, 2022
Researchers assess the effectiveness and safety outcomes of interleukin-1 blocking agents in the treatment of COVID-19.
January 24, 2022
This randomized clinical trial compares the effect of continuous positive airway pressure or high-flow nasal oxygen vs conventional oxygen therapy on clinical o
January 18, 2022
This randomized clinical trial evaluates the benefits and risks of the addition of a P2Y12 inhibitor to anticoagulant therapy compared with anticoagulant therap
January 18, 2022
Because venous and arterial thromboembolism are common among patients hospitalized with COVID-19, anticoagulant therapies were among the first to be evaluated i
January 11, 2022
RECOVERY results do not support aspirin use in this setting Treatment with aspirin did not bring about any clinically meaningful improvements in outcomes among patients hospitalized with Covid-19 in the large, randomized, open-label RECOVERY trial. Aspirin was not associated with reductions in 28-day mortality or in the risk of progression to invasive mechanical ventilation in
December 30, 2021
Study finds that compared with standard care, aspirin therapy did not significantly decrease the risk for all-cause mortality, invasive mechanical ventilation, renal dialysis, or hemofiltration among patients hospitalized with COVID-19.
November 27, 2021
This narrative review discusses what is currently known about the pathophysiology, epidemiology, diagnosis, management, prognosis, and prevention of coronavirus